SCHEMBL18376838

SCHEMBL18376838

COc1ccc(-c2cccc3cnc(Nc4cnc(N5CCN(C)CC5)nc4)nc23)cc1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ BRD4 O60885 3/20 0.49
▸ JAK2 O60674 3/20 0.49
▸ HRH4 Q9H3N8 1/20 0.48
▸ FGFR4 P22455 2/20 0.47
▸ AURKA O14965 1/20 0.47
▸ CDK4 P11802 1/20 0.47
▸ JAK1 P23458 1/20 0.47
▸ TYK2 P29597 1/20 0.47
▸ JAK3 P52333 1/20 0.47
▸ MAPK10 P53779 5/20 0.46
▸ JUN P05412 4/20 0.46
▸ MAPK8 P45983 4/20 0.46
▸ TTK P33981 3/20 0.45
▸ CCNA2 P20248 1/20 0.45
▸ CDK2 P24941 1/20 0.45
▸ CTSC P53634 1/20 0.44
▸ EGFR P00533 2/20 0.44
▸ KDR P35968 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29370835 1.00 BRD4 (0.49) BRD4JAK2HRH4FGFR4AURKA
SCHEMBL18377046 0.88 BRD4 (0.63) BRD4JAK2FGFR4AURKACDK4
SCHEMBL18376246 0.87 JAK2 (0.56) BRD4JAK2FGFR4AURKACDK4
SCHEMBL29371334 0.87 JAK2 (0.56) BRD4JAK2FGFR4AURKACDK4
SCHEMBL28120334 0.84 BRD4 (0.51) BRD4JAK2HRH4FGFR4AURKA
SCHEMBL29371298 0.84 JAK2 (0.51) BRD4JAK2FGFR4AURKACDK4
SCHEMBL18376806 0.84 JAK2 (0.51) BRD4JAK2FGFR4AURKACDK4
SCHEMBL18376659 0.83 BRD4 (0.49) BRD4JAK2HRH4FGFR4AURKA
SCHEMBL18376598 0.82 FGFR4 (0.59) JAK2FGFR4JAK3KDR
SCHEMBL29371309 0.82 FGFR4 (0.59) JAK2FGFR4JAK3KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113999180-A Quinazoline compound, intermediate thereof, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2022-02-01 — — CN claimed
CN-113999180-B Quinazoline compound, intermediate, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2024-03-26 — — CN disclosed
CN-113999180-A Quinazoline compound, intermediate thereof, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2022-02-01 — — CN disclosed
CN-106316965-B Quinazoline compound, intermediate thereof, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2021-08-27 — — CN disclosed
WO-2017005137-A1 QUINAZOLINE COMPOUND, INTERMEDIATE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USES THEREOF 吉林大学 2017-01-12 — — WO disclosed
Send feedback